Loading...
What the Clinical Microbiologist Should Know About PK/PD in the Era of Emerging Multidrug-Resistance: Beta-Lactam/Beta-Lactamase Inhibitor Combinations
As a class, β-lactamase inhibitors have proven successful in extending the clinical utility of β-lactam antibiotics by circumventing β-lactamase-mediated resistance. However, the rapid evolution of these β-lactamases calls for a critical re-evaluation of the relationships between susceptibility, dru...
Na minha lista:
| Udgivet i: | Clin Lab Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6686870/ https://ncbi.nlm.nih.gov/pubmed/31383269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cll.2019.05.006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|